MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis
Yuichi Iwaki, M.D., Ph.D., MediciNova CEO commented, “The successful resolution of the Sanofi-Novartis litigation and the resulting monetary damages due to MediciNova both validates the value of our ...
MediciNova notified of settlement in Sanofi Novartis litigation
MediciNova (MNOV) was notified by Sanofi (SNY) that the Sanofi/Novartis (NVS) litigation was settled. Accordingly, MediciNova is entitled to ...
SFGate1d
MediciNova: Q3 Earnings Snapshot
LA JOLLA, Calif. (AP) — LA JOLLA, Calif. (AP) — MediciNova Inc. (MNOV) on Wednesday reported a loss of $2.9 million in its third quarter. On a per-share basis, the La Jolla, California-based company ...
Eagle-Tribune22d
MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients ...
LA JOLLA, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock ...
Yahoo Finance1mon
MediciNova (NASDAQ:MNOV) shareholders have endured a 73% loss from investing in the stock five years ago
It is doubtless a positive to see that the MediciNova, Inc. (NASDAQ:MNOV) share price has gained some 45% in the last three months. But will that heal all the wounds inflicted over 5 years of ...
ETF Daily News7d
MediciNova (NASDAQ:MNOV) Share Price Crosses Above 200 Day Moving Average – Here’s Why
MediciNova, Inc. (NASDAQ:MNOV – Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday .The stock has a 200-day moving average of $1.50 and traded as high ...
MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a report released on Wednesday. The firm issued a hold rating on the biopharmaceutical company’s stock. MediciNova ...
CNN1y
MediciNova, Inc.
MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs. The company ...
75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight
DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...
Finanznachrichten1y
MediciNova, Inc.: MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis
LA JOLLA, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange ...
Wall Street Journal4y
MediciNova Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...